BLOC1S5 Knockout Jurkat Polyclonal Cells are a genetically modified polyclonal cell population derived from the Jurkat T-lymphocyte line through CRISPR/Cas9-mediated disruption of the BLOC1S5 gene. This product provides a versatile loss-of-function model for studying the BLOC-1 complex in an immune cell context. The polyclonal nature of the knockout pool captures a range of editing events, offering researchers a robust system to investigate BLOC1S5-dependent cellular processes without the clonal bias associated with single-cell-derived lines. The cells are supplied as a research-grade reagent suitable for molecular, biochemical, and cell biological assays.
The Jurkat host cell line is an immortalized human T-cell leukemia line widely used to study T-cell receptor (TCR) signaling, immune activation, and apoptosis. Jurkat cells retain many features of primary T lymphocytes, including surface receptor expression and downstream signal transduction machinery, making them a standard model for immunological investigations. Their leukemic origin also provides a link to oncogenic signaling pathways, and their rapid growth facilitates high-throughput screening and genetic manipulation. The integration of a BLOC1S5 knockout into this background enables direct examination of BLOC-1 function within a T-cell environment relevant to adaptive immunity and lymphoproliferative disorders.
BLOC1S5 encodes a subunit of the BLOC-1 complex, which mediates protein sorting from endosomes to lysosome-related organelles. The complex assembles with subunits BLOC1S1, BLOC1S2, BLOC1S3, BLOC1S4, BLOC1S6, SNAPIN, PLDN, and MUTED, and interacts with AP-3, Rab GTPases, and SNAREs to direct cargo such as TYRP1 to melanosomes and platelet dense granules. Loss of BLOC1S5 disrupts endosome-to-organelle trafficking, impairing organelle biogenesis. Upstream regulators remain largely undefined, though MITF and TFEB may influence BLOC-1 expression. Knockout models exhibit Hermansky-Pudlak syndrome type 8-like phenotypes, including pigmentation and platelet function defects.
In Jurkat T cells, BLOC1S5 knockout enables investigation of lysosome-related organelle function in immune processes. T cells employ secretory lysosomes for cytotoxicity and cytokine secretion, processes potentially dependent on BLOC-1-mediated trafficking. Disrupting BLOC1S5 can reveal how endosomal sorting defects affect TCR signaling, immune synapse formation, and effector responses. This cellular model offers a human platform to study Hermansky-Pudlak syndrome type 8 pathology, which involves oculocutaneous albinism, platelet dense granule deficiency, and possible immune impairment. The polyclonal population mitigates clonal variation, providing stable phenotypes for mechanistic and therapeutic studies.
These knockout cells are suitable for Western blotting, co-immunoprecipitation of BLOC-1 complex components, and immunofluorescence of lysosome-related organelles. Functional analyses include lysosomal pH measurement and secretion assays to quantify trafficking disruption. Transcriptomic profiling via RNA-seq can uncover downstream gene expression changes, and rescue experiments can confirm pathway specificity. This reagent is valuable for drug screens targeting protein trafficking and for studying organelle biogenesis in hematologic contexts. For additional information, contact Ascent Research.
